# RiaSTAP

NDC: 63833-891
Generic name: FIBRINOGEN HUMAN
Labeler / Manufacturer: CSL Behring GmbH
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20090116

FDA application: BLA125317

## Active ingredients

- FIBRINOGEN HUMAN: 1300 mg/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63833-891"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63833-891